REFERENCES
- Bennett MH, Feldmeier J, Hampson N. Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2005;(3):CD005005
- Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33:998–1003.
- Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. 1996;334:1642–1648.
- Undersea and Hyperbaric Medical Society Indications for hyperbaric oxygen therapy. Available at: http://membership. uhms.org/?page=Indications Accessed May 29, 2014.
- Wang C, Schwaitzberg S, Berliner E, Zarin DA, Lau J. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg. 2003;138:272–279.
- Wunderlich RP, Peters EJ, Lavery LA. Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care. 2000;23:1551–1555.
- Transdermal fentanyl package insert. Available at: http://www.mylan.com/products/packaging-and-delivery-systems/transdermal-technology. Accessed May 29, 2014.
- Lotsch J, Walter C, Parnham MJ, Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet. 2013;52:23–26.
- Lavonas EJ. Safety analysis of transdermal medication delivery systems in the hyperbaric environment. Available at: http://archive.rubicon-foundation.org/xmlui/handle/123456 789/3673?show=full. Accessed May 29, 2014.
- Roustan WK. Two charged in deadly 2009 hyperbaric chamber fire. Sun Sentinel, April 25, 2012. Available at: http:// articles.sun-sentinel.com/2012-04-25/news/fl-hyperbaric-cham ber-deaths-0426-20120425_1_francesco-martinisi-hyperbaric-clinic-pure-oxygen. Accessed July 31, 2014.
- Michniak BB, Piepmeier E, Stroman R, Effects of hyperbaric treatment on fentanyl release profiles from Druagesic® transdermal delivery systems. Pharm Res. 1996;13(9 Suppl):S-379.
- Shirley DA, Stroman R, Michniak BB, Effect of temperature and hyperbaric treatment on fentanyl release profiles form Duragesic® systems, part II. Pharm Res. 1997;14(1 Suppl)S-318–S-319.
- Yaksh TL, Wallace MS. Chapter 18. Opioids, Analgesia, and Pain Management. In: Brunton LL, Chabner BA, Knollmann BC. eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e. New York, NY: McGraw-Hill; 2011. http://accesspharmacy.mhmedical.com/content.aspx?bookid= 374&Sectionid=41266224. Accessed July 31, 2014.
- Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100:747–758.
- Kindwall EP. The use of drugs under pressure. In: Kindwall EP, Whelan HT, eds. Hyperbaric Medicine Practice, 3rd ed. Flagstaff, AZ: Best Publishing Company; 2008:245–261.
- Gallagher RM, Welz-Bosna M, Gammaitoni A. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain. Pain Med. 2007;8:71–74.
- Radbruch L, Abatowski R, Petzke F, Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med. 2001;15:309–321.
- American Pain Society. Principals of Analgesic Use in the Treatments of Acute Pain and Cancer Pain. 6th ed. Chicago: American Pain Society; 2008.
- US Department of Veterans Affairs. Management of opioid therapy for chronic pain. Available at: http://www.healthquality. va.gov/Chronic_Opioid_Therapy_COT.asp. Accessed May 29, 2014.